Workshop Highlights Jordan's Efforts To Combat Counterfeit D...| MENAFN.COM

Wednesday, 05 October 2022 12:47 GMT

Workshop Highlights Jordan's Efforts To Combat Counterfeit Drugs

(MENAFN- Jordan News Agency)

Amman, Aug. 11 (Petra)--Jordan Pharmacists Association (JPA), in cooperation with Jordan Customs Department (JCD), on Thursday organized a workshop entitled (Safe Medication...National and Legal Responsibility), launched by Director General of Jordanian Food & Drug Administration (JFDA), Dr. Nizar Mheidat.
During the event, JPA head, Mohammad Ababneh, said Jordan is classified a country that is free of counterfeit and smuggled drugs, at 0% rate.
Ababneh noted maintaining drug security and community health requires effective and safe drug delivery to the citizen at licensed and trusted pharmaceutical institutions.
In addition, he called for orchestrating JPA, JCD and JFDA efforts to activate monitoring standards on the mechanisms related to entry of drugs into the Kingdom at various border crossings.
Meanwhile, Mheidat referred to the increasing attempts to smuggle counterfeit medicines, which harm the patient's health and affect Jordan's drug reputation.
Jordanian official institutions are making efforts to monitor drug entry and exit into and out of the Kingdom and combat smuggling, Mheidat noted.
In this regard, he pointed to the JFDA's role in monitoring restricted drugs and regulating their entry and exit by implementing related laws and enacting the necessary legislation to prevent any misuse.
He also referred to JFDA's inspection tours to ensure drug quality locally and control smuggled and counterfeit medicines.
He called on the participants to produce specific recommendations to be implemented, according to a clear work mechanism, in cooperation with the concerned national institutions.


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.